POST-MARKET QUALITY SURVEILLANCE PROJECT MATERNAL HEALTHCARE PRODUCTS (OXYTOCIN AND ERGOMETRINE) ON THE GHANAIAN MARKET REPORT OF FIRST ROUND

A study, funded by US-Aid & run by the U.S. Pharmacopeia, was performed in Ghana on two life-saving medications used during labor — Oxytocin & Ergometrine. The results were both astonishing and scary.

Out of the 169 Oxytocin samples assayed, 55.62% failed. Of the 99 Ergometrine injection samples, 73.74% failed, and all of the 11 (100%) Ergometrine tablets tested failed assay.

The question is: How do the countries of origin (India and China) allow their Pharma companies to ship such poor quality medicines, especially those which have a life or death impact to countries in Africa? Who is accountable for this?

Original Report ➡️ Ghana Maternal Products Study